(via TheNewswire)

VANCOUVER, British Columbia, August 18, 2026 – TheNewswire – Frequency Exchange Corp. (TSXV: FREQ | OTC: FRECF | FSE: YC6) ("Frequency Exchange" or the "Company") is pleased to announce that NIKKI, its flagship frequency-based wellness platform and wearable delivery device, will be prominently featured in the documentary Superhuman 2: Rebirth , scheduled for release in September/October 2026.

Produced by award-winning filmmaker Caroline Cory, Superhuman2.com is a documentary focused on consciousness, frequencies, human potential and emerging wellness technologies. It features internationally recognized voices including Bruce Lipton, Gregg Braden, Michael Beckwith, Lynn McTaggart and Dr. Leigh Erin Connealy.

Among the technologies showcased throughout the documentary, NIKKI is featured as an example of next-generation wearable wellness technology.

NIKKI is a wearable wellness device and platform designed to deliver proprietary frequency-based wellness programs targeting areas such as sleep, stress, energy, recovery and overall vitality. The platform also features additional exclusive frequency-based programs showcased in Superhuman 2: Rebirth .

Click Image To View Full Size

GLOBAL AUDIENCE AND DISTRIBUTION PRECEDENT

The original Superhuman: The Invisible Made Visible documentary established a substantial international distribution footprint, with worldwide rights handled by 1091 Pictures and distribution across Digital HD, Cable VOD and DVD, followed by availability on major streaming platforms including Gaia, Amazon Prime Video, Apple TV and other digital services. The production has also been distributed with subtitles in French, Dutch, German, Portuguese, Japanese, Russian and Spanish.

Building on the international distribution precedent established by the original Superhuman documentary, Superhuman 2: Rebirth is expected to introduce international audiences to the growing field of frequency-based wellness. For Frequency Exchange, this represents an excellent opportunity to increase international awareness of the NIKKI device and platform as the Company advances commercialization.

"We evaluated numerous technologies during the production of Superhuman 2: Rebirth , and NIKKI stood out as one of the most compelling innovations we encountered," said Caroline Cory, Executive Producer and Director of Superhuman 2: Rebirth . "Its unique approach to delivering wellness frequencies through an elegant wearable platform aligns perfectly with the educational message of this film. I believe audiences around the world will be fascinated by what NIKKI represents."

Stephen Davis, CEO of Frequency Exchange, commented "This is an important milestone for our Company. To have NIKKI selected as one of the featured technologies in a documentary alongside many of the world’s leading voices in consciousness, health and human performance is a meaningful validation of the technology and our commercialization strategy. The September/October 2026 release coincides with our expanding commercial rollout, including recent distribution initiatives in the United States, the Middle East, and other international markets. To meet potential demand for our featured NIKKI device and platform we are building inventory and are in the process of finalizing additional distribution agreements.”

About Superhuman 2 Rebirth

Superhuman 2: Rebirth is a documentary experience that explores the remarkable potential within all of us. Through inspiring stories, thought-provoking ideas and conversations with leading experts, the documentary invites viewers to look beyond what they thought was possible and discover new perspectives on human potential, consciousness , and what it means to thrive. For more information, please visit www.superhuman2.com .

About Frequency Exchange Corp.

Frequency Exchange Corp. (TSXV: FREQ | OTC: FRECF | FSE: YC6) is a technology company building the next generation of wearable digital wellness solutions through its flagship platform, NIKKI®. Unlike traditional wearable devices that primarily monitor health metrics, NIKKI delivers personalized frequency-based wellness programs designed to support sleep, stress, recovery, energy and overall wellbeing. Originally developed through research supporting individuals living with Lyme disease, NIKKI has evolved into a scalable wearable digital wellness platform addressing some of today’s largest global health challenges.

For additional information, visit www.frequencyexchangecorp.com or www.wearenikki.com

About SEED Group, Our Partner

For over 20 years, Seed Group has formed strategic alliances with leading global companies representing diverse regions and industries. These companies have propelled their business interests and goals in the Middle East and North Africa region through the support and strong base of regional connections of the Seed Group. The Group’s goal is to create mutually beneficial partnerships with multinational organizations and to accelerate their sustainable market entry and presence within the MENA region. Seed Group has been a key point in the success of all its partners in the region, helping them reach their target customers and accelerate their businesses. The Private Office was established by Sheikh Saeed bin Ahmed Al Maktoum to directly invest in or assist potential business opportunities in the region, which meet The Private Office’s criteria.

For additional information, visit www.SEEDGroup.com

More information is available at:

www.FrequencyExchangeCorp.com

www.WeAreNikki.com

Investor Contacts

Frequency Exchange Corp.                        FREmedica Technologies Inc.

Stephen Davis                                         Nicole Sullivan

Chief Executive Officer                                 President

stephen@frequencyexchangecorp.com                 nicole.sullivan@wearenikki.com

604-684-2181                                         604-684-2181

Forward-Looking Information

This news release contains forward-looking statements within the meaning of applicable securities laws. These statements reflect the Company’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements.

Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company’s profile on SEDAR+ at www.sedarplus.ca .

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.